PhRMA published a press release announcing that Sanofi's CEO Chris Viehbacher will take over as the new Board Chairman for the outgoing Jeff Kindler of Pfizer. Viehbacher took the opportunity of his appointment to outline the pharma industy's priorities:
- Putting patients first by delivering innovative medicines that address unmet medical needs
- Prevention and better management of chronic diseases
Chronic diseases give rise to 75% of the national healthcare spend so addressing these is an important measure of controlling overall costs - albeit through better health for patients. PhRMA will continue to stress medical innovation to patients, policies that reward investment in R&D, economic growth and jobs.
Posted by Bruce Lehr December 6th 2010.